Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Invion ( (AU:IVX) ).
Invion Limited announced an update to its previous securities issuance, adjusting capacity calculations to utilize 6,641,068 shares from section 7.1A and 394,379 from section 7.1. This update reflects the company’s strategic financial maneuvering to optimize its market position and potentially enhance shareholder value.
More about Invion
Invion Limited operates in the biotechnology sector, focusing on the development and commercialization of innovative medical therapies. The company is primarily involved in creating solutions for the treatment of chronic inflammatory diseases.
Average Trading Volume: 110
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.97M
For detailed information about IVX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue